Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BD Issues 2021 Global Inclusion, Diversity and Equity Report

12/01/2021 | 06:51am EST

FRANKLIN LAKES, N.J., Dec. 1, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its 2021 Global Inclusion, Diversity and Equity (ID&E) Report.

The report, titled "Together We Advance ID&E," highlights the progress BD is making in a critical aspect of human health, which is one of four pillars in the company's environmental, social and governance (ESG) strategy. BD's commitment to ID&E sets a new standard for how the company will work together to innovate new products and solutions to deliver what's next in health care.

The ID&E systems, processes and tools that drive action and accountability at BD are detailed in the report. They are the foundation from which BD will continue to accelerate its ID&E efforts to achieve the company's 2030+ goals with respect to maintaining a healthy and thriving workforce that cultivates the company's culture of inclusion, safety, well-being and also contributes to community and company health.

"The pillars of our ESG strategy are interconnected, and our ID&E programs are essential in helping us make a meaningful impact in the areas of company, planet, community and human health," said Tom Polen, chairman, CEO and president of BD. "We have been on a journey to build a more inclusive workplace where the members of our global team can be themselves, feel comfortable speaking up, grow and develop in their careers, and share their best and most innovative thinking. When more people and perspectives have a seat at the table, we produce better, more innovative solutions for the health care industry."

The 2030+ goals, which were set last month, include improving ethnic and gender diversity by 1% year over year at the management and executive levels, and ensuring equal pay (by gender) worldwide. Globally, at the end of FY2021 women held 39.9% of management roles and 29.9% of executive positions at BD, improvements from the prior year and above health care industry benchmarks. In addition, 30.2% of BD's U.S. workforce is ethnically diverse at the management level, and 21.2% at the executive level. Further demographic data will be released in the FY2021 Sustainability Report.

"While we've seen increases in ethnic and gender diversity, we are hard at work to continue adding to this progress," said Nicole Thompson, vice president of HR – Inclusion, Diversity, Equity & Engagement at BD. "We are well-positioned to meet and exceed increasing expectations from our employees, customers, shareholders and the communities we serve by accelerating ID&E programs that will help us advance the world of health for all."

As part of BD's commitment to ID&E, it regularly participates in external benchmarking surveys to track progress and provide additional visibility to stakeholders. In 2021, it was named to prestigious lists in recognition of the company's inclusive policies and practices, including:

  • Named a top company for diversity in the U.S. by DiversityInc.
  • 100% score on the Human Rights Campaign's Corporate Equality Index and named one of the best places to work for LGBT Equality.
  • 90% score on DisabilityIN's Disability Equality Index and named as a best place to work for Disability Inclusion.

For more information about the company's ID&E programs, visit https://www.bd.com/en-us/company/careers/inclusion-and-diversity.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:


Troy Kirkpatrick

Nadia Goncalves

VP, Public Relations

Senior Director, Investor Relations

858.617.2361

201.847.5934         

troy.kirkpatrick@bd.com  

nadia.gonclaves@bd.com    

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-issues-2021-global-inclusion-diversity-and-equity-report-301434621.html

SOURCE BD (Becton, Dickinson and Company)


ę PRNewswire 2021
All news about BECTON, DICKINSON AND COMPANY
01/20BD Innovation Profiled in Cover Story of 'Science' Demonstrates Landmark Advancement in..
PR
01/12BD Named One of America's Most Just Companies in Annual JUST 100 Ranking
AQ
01/11BD, Pfizer, Wellcome Collaborate to Improve Global Hospital Antimicrobial Stewardship P..
PR
01/11Becton, Dickinson and Company and Pfizer Inc Collaborates to Improve Global Hospital An..
CI
01/11US to Require Insurers to Pay for At-Home COVID-19 Tests
MT
01/10BD Introduces Smart Connected Robotics to Automate Microbial Identification
AQ
01/07Becton, Dickinson, and Co. Gets US FDA 510(k) Clearance for Bacterial Identification Te..
MT
01/07BD Introduces Smart Connected Robotics to Automate Microbial Identification
PR
01/07Becton, Dickinson and Company Receives 510(K) Clearance from the U.S. Food and Drug Adm..
CI
01/06BD Announces Change to Virtual 2022 Annual Meeting of Shareholders
PR
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations